pioglitazone has been researched along with colforsin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bajwa, PJ; Lee, JW; Lytle, C; Straus, DS | 1 |
Hosaka, T; Inukai, K; Ishida, H; Katsuta, H; Kitahara, A; Moriya, R; Nishida, S; Onuma, H; Sumitani, Y; Takahashi, K; Tanaka, T | 1 |
2 other study(ies) available for pioglitazone and colforsin
Article | Year |
---|---|
Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
Topics: Administration, Oral; Animals; Calcium; Carbachol; Chlorides; Cholera Toxin; Colforsin; Colon; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Disease Models, Animal; Electric Impedance; Female; Gastrointestinal Agents; HT29 Cells; Humans; Ileum; Intermediate-Conductance Calcium-Activated Potassium Channels; Intestinal Mucosa; Intestinal Secretions; Intestines; Jejunum; KCNQ1 Potassium Channel; Mice; Pioglitazone; PPAR gamma; Rosiglitazone; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Thiazolidinediones; Time Factors | 2009 |
The glucagon-like peptide 1 receptor agonist enhances intrinsic peroxisome proliferator-activated receptor γ activity in endothelial cells.
Topics: Anilides; Colforsin; Cyclic AMP-Dependent Protein Kinases; Endothelial Cells; Exenatide; Gene Expression; Glucagon-Like Peptide-1 Receptor; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Isoquinolines; NADPH Oxidase 1; NADPH Oxidases; NF-kappa B; Peptides; Phosphorylation; Pioglitazone; PPAR gamma; Protein Kinase Inhibitors; Receptor Cross-Talk; Receptors, Glucagon; Signal Transduction; Sulfonamides; Thiazolidinediones; Vascular Cell Adhesion Molecule-1; Venoms | 2014 |